Prof. Dr. med. David Julian Seiffge

Projects

Randomized controlled trials (steering committee member/national leader):

• Trial of Andexanet in ICH Patients Receiving an Oral FXa Inhibitor (ANNEXA-I)
• EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
• Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist (TICH-NOAC)

Observational cohort studies (Principal investigator or steering committee member):

• Novel Oral Anticoagulants in Stroke Patients (NOACISP)
• Stroke despite treatment with blood thinners: causes and outcomes
• Swiss Intracerebral haemorrhage imaging cohort study
• Prognosis of cerebral small vessel disease – a prospective cohort study (PRO-SVD)

Research fields

• Intracerebral hemorrhage
• Anticoagulation and stroke
• Cerebral Small vessel disease
• Rare cerebrovascular syndromes (PRES and RCVS)

Collaborations:

• Prof. Dr. David Werring, UCL Queen Square Institute of Neurology Stroke Research Center
• PD Dr. Gian Marco De Marchis, Universitätsspital Basel
• Prof. Dr. Stefan Engelter, Felix Platter Spital Basel
• Prof. Dr. Philippe Lyrer, Universitätsspital Basel
• Prof. Dr. Urs Fischer, Universitätsspital Basel
• Assistant Professor Shadi Yaghi, Comprehensive Stroke Center, Rhode Island Hospital and Brown University, USA
• Associated Professor Ashkan Shoamanesh, McMaster University, Hamilton Canada
• PD Dr. Jan Purrucker, Universtitäsklinik Heidelberg, Deutschland
• Prof. Dr. med. Christian Nolte, Charite Berlin, Deutschland
• Prof. Dr. Jan Scheitz, Charite Berlin, Deutschland
• Dr. Teddy Wu and Dr. Dunan Wilson, Christchurch, NZ